Chemical Structure (Zorvolex 01)
Zorvolex
Product Images NDC 42211-203
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zorvolex (NDC 42211-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Iroko Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Zorvolex 02)
This is a chart displaying the mean VAS (Visual Analog Scale) pain intensity score over time (in hours) for a study comparing Zorvolex Capsules (with dosages of 35 mg and 18 mg taken three times a day) to a placebo.*
Figure 2 (Zorvolex 03)
This is a chart showing the proportion of patients who achieved reduction in WOMAC pain subscale scores after taking Zorvolex Capsules 35mg TID or placebo. The chart also includes the percentage reduction from baseline in WOMAC Pain Subscale Scores.*
Principal Display Panel (18 mg Capsule Bottle Label)
Principal Display Panel (35 mg Capsule Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
